Penumbra, Inc. (PEN)

Penumbra, Inc. is a global healthcare company that specializes in innovative medical devices and technologies for treating various conditions, particularly in the neurovascular and peripheral vascular areas. Founded in 2004 by Adam Elsesser, who also serves as the CEO, the company has established itself as a leader in the field of minimally invasive medical treatments. Penumbra's product portfolio includes devices for thrombectomy, embolization, and access technologies, which are essential in treating conditions like stroke. Headquartered in Alameda, California, Penumbra has expanded its operations and sales networks internationally. The company has been publicly traded on the New York Stock Exchange under the ticker symbol "PEN" since 2015. As of recent years, Penumbra has continued to see growth in its revenue, reflecting its commitment to advancing healthcare through innovation and its expanding global reach.